Gland Pharma Ltd (GLAND) Shareholding Pattern - Promoter, FII, DII & Public Holdings
As of Jun 2026, promoters held 51.77% of Gland Pharma Ltd, FIIs 8.74%, DIIs 30.44%, government - and the public 9.06%, across 1,08,266 shareholders.
| Metric | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 51.83% | 51.83% | 51.83% | 51.83% | 51.83% | 51.83% | 51.83% | 51.77% |
| FIIs | 4.48% | 5.04% | 6.9% | 7.39% | 7.9% | 7.58% | 7.29% | 8.74% |
| DIIs | 35.37% | 34.8% | 33.27% | 32.86% | 32.63% | 32.99% | 33.36% | 30.44% |
| Public | 8.33% | 8.33% | 8% | 7.93% | 7.63% | 7.62% | 7.52% | 9.06% |
| No. of Shareholders | 1,22,358 | 1,21,075 | 1,13,788 | 1,10,671 | 97,151 | 94,578 | 91,500 | 1,08,266 |